[go: up one dir, main page]

GB9618966D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9618966D0
GB9618966D0 GBGB9618966.7A GB9618966A GB9618966D0 GB 9618966 D0 GB9618966 D0 GB 9618966D0 GB 9618966 A GB9618966 A GB 9618966A GB 9618966 D0 GB9618966 D0 GB 9618966D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9618966.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9618966.7A priority Critical patent/GB9618966D0/en
Publication of GB9618966D0 publication Critical patent/GB9618966D0/en
Priority to EP97939071A priority patent/EP0912747A1/fr
Priority to PCT/GB1997/002426 priority patent/WO1998011236A1/fr
Priority to JP10513354A priority patent/JP2000501623A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478Aspartic endopeptidases (3.4.23)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB9618966.7A 1996-09-11 1996-09-11 Novel compounds Pending GB9618966D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9618966.7A GB9618966D0 (en) 1996-09-11 1996-09-11 Novel compounds
EP97939071A EP0912747A1 (fr) 1996-09-11 1997-09-09 Protease aspartique
PCT/GB1997/002426 WO1998011236A1 (fr) 1996-09-11 1997-09-09 Protease aspartique
JP10513354A JP2000501623A (ja) 1996-09-11 1997-09-09 アスパラギン酸プロテアーゼ

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9618966.7A GB9618966D0 (en) 1996-09-11 1996-09-11 Novel compounds

Publications (1)

Publication Number Publication Date
GB9618966D0 true GB9618966D0 (en) 1996-10-23

Family

ID=10799763

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9618966.7A Pending GB9618966D0 (en) 1996-09-11 1996-09-11 Novel compounds

Country Status (4)

Country Link
EP (1) EP0912747A1 (fr)
JP (1) JP2000501623A (fr)
GB (1) GB9618966D0 (fr)
WO (1) WO1998011236A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69738653T2 (de) * 1996-11-20 2009-06-04 Oklahoma Medical Research Foundation, Oklahoma Klonierung und charakterisierung von napsin, einer aspartat-protease
EP0897986A3 (fr) * 1997-08-21 2000-07-05 Smithkline Beecham Corporation Protéinase aspartique 5
US7045333B1 (en) 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules
US6432690B1 (en) 1998-01-16 2002-08-13 Incyte Genomics, Inc. Human aspartic proteases
US7160679B1 (en) 1998-05-21 2007-01-09 Diadexus, Inc. Method of diagnosing, monitoring, and staging lung cancer
CA2303062A1 (fr) * 1998-07-16 2000-01-27 Incyte Pharmaceuticals, Inc. Proteases aspartiques humaines
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
NZ534876A (en) 1999-02-10 2006-02-24 Elan Pharm Inc Human beta-secretase enzyme, inhibitors and their compositions and uses
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
EP1500663A1 (fr) * 2000-09-28 2005-01-26 Eli Lilly And Company Protéines secrétées et leurs utilisations.
AU2003268023A1 (en) * 2002-07-23 2004-02-09 Incyte Corporation Protein modification and maintenance molecules

Also Published As

Publication number Publication date
WO1998011236A1 (fr) 1998-03-19
JP2000501623A (ja) 2000-02-15
EP0912747A1 (fr) 1999-05-06

Similar Documents

Publication Publication Date Title
EP0914330A4 (fr) Composes de type nouveau
EP0904104A4 (fr) Nouveaux composes
EP0907375A4 (fr) Nouveaux composes
AP9701047A0 (en) Novel compounds
GB9605945D0 (en) Novel compounds
GB9614347D0 (en) Novel compounds
GB9600955D0 (en) Novel compounds
AP9701037A0 (en) Novel compounds
GB9604045D0 (en) Novel compounds
GB9601041D0 (en) Novel compounds
GB9601069D0 (en) Novel compounds
GB9605381D0 (en) Novel compounds
GB9605883D0 (en) Novel compounds
GB9606396D0 (en) Novel compounds
EP0954525A4 (fr) Nouveaux composes
EP0907377A4 (fr) Nouveaux composes
GB9601066D0 (en) Novel compounds
GB9606208D0 (en) Novel compounds
GB9606209D0 (en) Novel compounds
GB9604584D0 (en) Novel compounds
GB9606395D0 (en) Novel compounds
GB9606207D0 (en) Novel compounds
GB9606198D0 (en) Novel compounds
GB9606397D0 (en) Novel compounds
GB9606398D0 (en) Novel compounds